DGX logo

Quest Diagnostics Incorporated Stock Price

NYSE:DGX Community·US$20.2b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 24 Fair Values set on narratives written by author

DGX Share Price Performance

US$181.44
33.63 (22.75%)
3.6% undervalued intrinsic discount
US$188.19
Fair Value
US$181.44
33.63 (22.75%)
3.6% undervalued intrinsic discount
US$188.19
Fair Value
Price US$181.44
AnalystConsensusTarget US$188.19

DGX Community Narratives

AnalystConsensusTarget·
Fair Value US$188.19 3.9% undervalued intrinsic discount

Preventive Diagnostics And Automation Will Shape Future Healthcare

0users have liked this narrative
0users have commented on this narrative
12users have followed this narrative

Recent DGX News & Updates

Earnings Not Telling The Story For Quest Diagnostics Incorporated (NYSE:DGX)

Aug 20
Earnings Not Telling The Story For Quest Diagnostics Incorporated (NYSE:DGX)

Quest Diagnostics Incorporated Key Details

US$10.5b

Revenue

US$7.0b

Cost of Revenue

US$3.5b

Gross Profit

US$2.6b

Other Expenses

US$945.0m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Oct 21, 2025
Earnings per share (EPS)
8.45
Gross Margin
33.22%
Net Profit Margin
8.98%
Debt/Equity Ratio
77.2%

Quest Diagnostics Incorporated Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Undervalued established dividend payer.

1 Risk
5 Rewards

About DGX

Founded
1967
Employees
50500
CEO
James Davis
WebsiteView website
www.questdiagnostics.com

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, emerging retail healthcare providers, pharmaceutical companies and insurers, commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Market Insight

Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading

U.S. Market Performance

  • 7 Days: 0.3%
  • 3 Months: 8.5%
  • 1 Year: 17.3%
  • Year to Date: 15.0%
Over the last 7 days, the market has remained flat, with no particular sector making any big moves this week. As for the longer term, the market has risen 17% in the past 12 months. Earnings are forecast to grow by 15% annually. Market details ›